Agile Therapeutics, Inc.
Dermal Delivery Device
Last updated:
Abstract:
A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of less than 5% and/or achieves a meaningful degree of detachment over a seven day period of less than 20%.
Status:
Application
Type:
Utility
Filling date:
19 Oct 2020
Issue date:
4 Feb 2021